NCI-MATCH: T-DM1 shows promising activity in salivary gland cancer
The antibody-drug conjugate ado-trastuzumab emtansine (T-DM1) has promising activity in HER2 amplified salivary gland tumors, according to data published in the Annals of Oncology. The publication is for 'Arm Q,' which is ...
Jan 7, 2020
0
2
